APA (7th ed.) Citation

Burza, S., Mahajan, R., Kazmi, S., Alexander, N., Kumar, D., Kumar, V., . . . Pandey, K. (2022). AmBisome Monotherapy and Combination AmBisome–Miltefosine Therapy for the Treatment of Visceral Leishmaniasis in Patients Coinfected With Human Immunodeficiency Virus in India: A Randomized Open-Label, Parallel-Arm, Phase 3 Trial. Clinical Infectious Diseases, 75(8), 1423. https://doi.org/10.1093/cid/ciac127

Chicago Style (17th ed.) Citation

Burza, Sakib, et al. "AmBisome Monotherapy and Combination AmBisome–Miltefosine Therapy for the Treatment of Visceral Leishmaniasis in Patients Coinfected With Human Immunodeficiency Virus in India: A Randomized Open-Label, Parallel-Arm, Phase 3 Trial." Clinical Infectious Diseases 75, no. 8 (2022): 1423. https://doi.org/10.1093/cid/ciac127.

MLA (9th ed.) Citation

Burza, Sakib, et al. "AmBisome Monotherapy and Combination AmBisome–Miltefosine Therapy for the Treatment of Visceral Leishmaniasis in Patients Coinfected With Human Immunodeficiency Virus in India: A Randomized Open-Label, Parallel-Arm, Phase 3 Trial." Clinical Infectious Diseases, vol. 75, no. 8, 2022, p. 1423, https://doi.org/10.1093/cid/ciac127.